Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Orthop Res. 2019 Sep 6;38(1):139–149. doi: 10.1002/jor.24451

Figure 5.

Figure 5.

Flexor explants were incubated with CM with or without DEX from day 2–7 to simulate BTM injury and treated injury in the absence of living muscle and bone (n=5/group/timepoint). (A) Otherwise healthy FDL explants (Inline graphic) remain viable for the entire 7-day culture period. (B) FDL+CM explants have reduced viability after 24 hours in CM that persists through day 7. (C) FDL+CM+DEX explants demonstrated rescued viability compared to the FDL+CM group. While there were no differences in (D) metabolism, (E) DNA, (F) total collagen, (G) sGAG, (H) sGAG synthesis, and (I) proliferation were all reduced in FDL+CM explants (Inline graphic). DEX treatment (Inline graphic) further reduced metabolic activity, sGAG synthesis, and proliferation but rescued matrix loss in total collagen and sGAG. Data are presented as mean ± 95% confidence interval where significant differences compared to the FDL control group are represented by stars (*) and compared to the FDL+CM group are represented by the scarab symbol (¤). Trends are additionally denoted by a hashtag symbol (#).